Annual Long Term Debt
$88.35 M
-$6.78 M-7.12%
31 December 2023
Summary:
Allogene Therapeutics annual long term debt is currently $88.35 million, with the most recent change of -$6.78 million (-7.12%) on 31 December 2023. During the last 3 years, it has risen by +$37.54 million (+73.88%). ALLO annual long term debt is now -7.12% below its all-time high of $95.12 million, reached on 31 December 2022.ALLO Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$85.14 M
-$1.85 M-2.13%
30 September 2024
Summary:
Allogene Therapeutics quarterly long term debt is currently $85.14 million, with the most recent change of -$1.85 million (-2.13%) on 30 September 2024. Over the past year, it has dropped by -$4.97 million (-5.51%). ALLO quarterly long term debt is now -13.33% below its all-time high of $98.23 million, reached on 30 June 2022.ALLO Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALLO Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.1% | -5.5% |
| 3 y3 years | +73.9% | +68.1% |
| 5 y5 years | +156.4% | +125.9% |
ALLO Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -7.1% | +73.9% | -13.3% | +68.1% |
| 5 y | 5 years | -7.1% | +156.4% | -13.3% | +125.9% |
| alltime | all time | -7.1% | +156.4% | -13.3% | +231.8% |
Allogene Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $85.14 M(-2.1%) |
| June 2024 | - | $86.99 M(-2.2%) |
| Mar 2024 | - | $88.92 M(+0.6%) |
| Dec 2023 | $88.35 M(-7.1%) | $88.35 M(-1.9%) |
| Sept 2023 | - | $90.10 M(-1.9%) |
| June 2023 | - | $91.82 M(-1.8%) |
| Mar 2023 | - | $93.51 M(-1.7%) |
| Dec 2022 | $95.12 M(+36.0%) | $95.12 M(-1.6%) |
| Sept 2022 | - | $96.71 M(-1.6%) |
| June 2022 | - | $98.23 M(+42.3%) |
| Mar 2022 | - | $69.03 M(-1.3%) |
| Dec 2021 | $69.93 M | $69.93 M(+38.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $50.64 M(-1.1%) |
| June 2021 | - | $51.21 M(-0.8%) |
| Mar 2021 | - | $51.63 M(+1.6%) |
| Dec 2020 | $50.81 M(-1.1%) | $50.81 M(-0.1%) |
| Sept 2020 | - | $50.85 M(-0.4%) |
| June 2020 | - | $51.07 M(-0.9%) |
| Mar 2020 | - | $51.54 M(+0.4%) |
| Dec 2019 | $51.35 M(+49.0%) | $51.35 M(+36.2%) |
| Sept 2019 | - | $37.69 M(+8.1%) |
| June 2019 | - | $34.87 M(+0.2%) |
| Mar 2019 | - | $34.81 M(+1.0%) |
| Dec 2018 | $34.46 M | $34.46 M(+34.3%) |
| Sept 2018 | - | $25.66 M |
FAQ
- What is Allogene Therapeutics annual long term debt?
- What is the all time high annual long term debt for Allogene Therapeutics?
- What is Allogene Therapeutics annual long term debt year-on-year change?
- What is Allogene Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Allogene Therapeutics?
- What is Allogene Therapeutics quarterly long term debt year-on-year change?
What is Allogene Therapeutics annual long term debt?
The current annual long term debt of ALLO is $88.35 M
What is the all time high annual long term debt for Allogene Therapeutics?
Allogene Therapeutics all-time high annual long term debt is $95.12 M
What is Allogene Therapeutics annual long term debt year-on-year change?
Over the past year, ALLO annual long term debt has changed by -$6.78 M (-7.12%)
What is Allogene Therapeutics quarterly long term debt?
The current quarterly long term debt of ALLO is $85.14 M
What is the all time high quarterly long term debt for Allogene Therapeutics?
Allogene Therapeutics all-time high quarterly long term debt is $98.23 M
What is Allogene Therapeutics quarterly long term debt year-on-year change?
Over the past year, ALLO quarterly long term debt has changed by -$4.97 M (-5.51%)